Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,814,974 papers from all fields of science
Search
Sign In
Create Free Account
BCVP protocol
Known as:
BCOP
, BCVP
, Carmustine/Cyclophosphamide/Prednisone/Vincristine
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (4)
Antineoplastic Combined Chemotherapy Protocols
Carmustine
Cyclophosphamide
cisplatin/cyclophosphamide/etoposide protocol
Prednisone
Vincristine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Antimicrobial, antifungal effect and safety verification using BCOP assay of extracts fromCoptis chinensis
Eun-Hee Kim
,
Young-Ah Jang
,
Sol-Bi Kim
,
Hankon Kim
,
Jin-Tae Lee
Journal of Applied Biological Chemistry
2018
Corpus ID: 55241729
황련은 한의학에서 진정, 소염, 항균 및 해열에 쓰이고 있으며, 주성분인 berberine…
Expand
2017
2017
CON4EI: Development of serious eye damage and eye irritation testing strategies with respect to the requirements of the UN GHS/EU CLP hazard categories.
S. Verstraelen
,
A. R. Van Rompay
Toxicology in Vitro
2017
Corpus ID: 22371730
1999
1999
BCOP: a New Regimen for the Oncology Pharmacist
J. Siderov
1999
Corpus ID: 75729275
1985
1985
Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial.
R. Gams
,
M. Rainey
,
M. Dandy
,
A. Bartolucci
,
H. Silberman
,
G. Omura
Journal of Clinical Oncology
1985
Corpus ID: 2511207
A total of 296 evaluable patients with unfavorable categories of malignant lymphoma were randomly assigned treatment with…
Expand
1983
1983
Sequential cyclophosphamide‐prednisone and vincristine‐bleomycin (CPOB). An effective, schedule‐dependent treatment for advanced diffuse histiocytic lymphoma
G. Johnson
,
W. Costello
,
+7 authors
C. Berard
Cancer
1983
Corpus ID: 24977930
In an Eastern Cooperative Oncology Group non‐Hodgkin's lymphoma clinical trial, 90 patients with Stage III or IV diffuse…
Expand
1980
1980
Moderate versus intensive chemotherapy of prognostically favorable non‐Hodgkin's lymphoma a progress report
E. Ezdinli
,
W. Costello
,
M. N. Silverstein
,
C. Berard
,
R. Hartsock
,
J. Sokal
Cancer
1980
Corpus ID: 3036872
Two hundred and fifty‐two patients with advanced stages of favorable non‐Hodgkin's lymphoma (NHL) subtypes (nodular histiocytic…
Expand
Review
1978
Review
1978
Treatment of histiocytic and mixed lymphomas. A comparison of two, three and four drug chemotherapy
R. Lenhard
,
E. Ezdinli
,
+5 authors
J. Wolter
Cancer
1978
Corpus ID: 6062574
The Eastern Cooperative Oncology Group has studied 187 patients with generalized progressive malignant lymphoma classified as…
Expand
1977
1977
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
J. Durant
,
R. Gams
,
A. Bartolucci
,
R. Dorfman
Cancer treatment reports
1977
Corpus ID: 10281828
Two hundred and ninety-eight evaluable patients with non-Hodgkin's lymphoma were stratified according to histology, treated with…
Expand
Highly Cited
1976
Highly Cited
1976
Management of small cell carcinoma of the lung. Therapy, staging, and biochemical markers
M. Abeloff
,
D. Ettinger
,
S. Baylin
,
T. Hazra
Cancer
1976
Corpus ID: 32437000
A chemotherapeutic regimen consisting of BCNU, cyclophosphamide, vincristine, and procarbazine was evaluated in 43 patients with…
Expand
1976
1976
Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas. A progress report
E. Ezdinli
,
S. Pocock
,
+12 authors
P. Carbone
Cancer
1976
Corpus ID: 568218
In an Eastern Cooperative Oncology Group trial, Cytoxan‐prednisone (CP) Induction was compared to BCNU‐prednisone (BP) in 273…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE